Endocrine Society GUIDELINES Bundle (free trial)

Menopause

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1140187

Contents of this Issue

Navigation

Page 7 of 19

Treatment 8 Hormone Therapy for Menopausal Symptom Relief Estrogen and Progestogen Therapy Î For menopausal women <60 years of age or <10 years past menopause with bothersome vasomotor symptoms (VMS) (with or without additional climacteric symptoms) who do not have contraindications or excess cardiovascular or breast cancer risks and are willing to take menopausal hormone therapy (MHT), ES suggests initiating estrogen therapy (ET) for those without a uterus and estrogen plus progestogen therapy (EPT) for those with a uterus. (2|⊕⊕ ) Cardiovascular Risk Î For women

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Menopause